| scholarly article | Q13442814 |
| P356 | DOI | 10.1056/NEJM200001273420401 |
| P698 | PubMed publication ID | 10648763 |
| P50 | author | Kathleen Neuzil | Q76169016 |
| Marie R. Griffin | Q89613053 | ||
| P2093 | author name string | Mellen BG | |
| Wright PF | |||
| Mitchel EF Jr | |||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | hospitalization | Q3140971 |
| P304 | page(s) | 225-231 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | The New England Journal of Medicine | Q582728 |
| P1476 | title | The effect of influenza on hospitalizations, outpatient visits, and courses of antibiotics in children. | |
| P478 | volume | 342 |
| Q30395222 | 2009 pandemic influenza A (H1N1) virus infection in pediatric oncology and hematopoietic stem cell transplantation patients. |
| Q57101803 | 2009 pandemic influenza a vaccination of pregnant women--King County, Washington State, 2009-2010 |
| Q56991712 | A Multiplex Asymmetric Reverse Transcription-PCR Assay Combined With an Electrochemical DNA Sensor for Simultaneously Detecting and Subtyping Influenza A Viruses |
| Q43175321 | A four-stage strategy to reduce childhood pneumonia-related mortality by 2015 and beyond |
| Q43173023 | A method for estimating vaccine-preventable pediatric influenza pneumonia hospitalizations in developing countries: Thailand as a case study |
| Q33593712 | A near-fatal infection with oseltamivir-resistant seasonal influenza A in a previously healthy child: Case report |
| Q37252918 | A novel influenza virus hemagglutinin-respiratory syncytial virus (RSV) fusion protein subunit vaccine against influenza and RSV |
| Q64132044 | A personnel time-motion study of intranasal influenza vaccination in healthy children |
| Q34291070 | A phase 1, open-label safety and immunogenicity study of an AS03-adjuvanted trivalent inactivated influenza vaccine in children aged 6 to 35 months. |
| Q43210853 | A prospective, Internet-based study of the effectiveness and safety of influenza vaccination in the 2001–2002 influenza season |
| Q58168175 | A randomized clinical trial assessing immunogenicity and safety of a double dose of virosomal-adjuvanted influenza vaccine administered to unprimed children aged 6–35 months |
| Q37530395 | A randomized controlled study to evaluate the immunogenicity of a trivalent inactivated seasonal influenza vaccine at two dosages in children 6 to 35 months of age |
| Q89530685 | A severe influenza season in Austria and its impact on the paediatric population: mortality and hospital admission rates, november 2017 - march 2018 |
| Q73034690 | A study of influenza and influenza-related complications among children in a large US health insurance plan database |
| Q34509883 | A time-series analysis of clostridium difficile and its seasonal association with influenza |
| Q47658890 | AS03- and MF59-Adjuvanted Influenza Vaccines in Children |
| Q47727515 | Accuracy of clinical diagnosis of influenza in outpatient children |
| Q30391956 | Activation of the innate immune system provides broad-spectrum protection against influenza A viruses with pandemic potential in mice |
| Q37976540 | Adjuvanted influenza vaccines |
| Q37885249 | Admission diagnoses of children 0-16 years of age hospitalized with influenza |
| Q91784573 | Age inappropriate influenza vaccination in infants less than 6 months old, 2010-2018 |
| Q36647988 | Age-related trends in the timeliness and prediction of medical visits, hospitalizations and deaths due to pneumonia and influenza, British Columbia, Canada, 1998-2004 |
| Q50754289 | An economic analysis of annual influenza vaccination of children. |
| Q59793789 | Analysing the link between public transport use and airborne transmission: mobility and contagion in the London underground |
| Q38067243 | Animal models for neonatal diseases in humans |
| Q34291016 | Antenatal immunization |
| Q37173332 | Antibody responses after inactivated influenza vaccine in young children |
| Q35217208 | Antiviral effect of methylated flavonol isorhamnetin against influenza. |
| Q30393095 | Antivirals for influenza: strategies for use in pediatrics |
| Q35661210 | Are we ready for universal influenza vaccination in paediatrics? |
| Q34687309 | Assessing parents' knowledge and attitudes towards seasonal influenza vaccination of children before and after a seasonal influenza vaccination effectiveness study in low-income urban and rural Kenya, 2010-2011. |
| Q50928587 | Assessing the acceptability and feasibility of a school-located influenza vaccination program with third-party billing in elementary schools. |
| Q33931458 | Assessing the burden of paediatric influenza in Europe: the European Paediatric Influenza Analysis (EPIA) project |
| Q38045920 | Assessing the safety of influenza vaccination in specific populations: children and the elderly |
| Q30847472 | Assessment of the efficacy and effectiveness of influenza vaccines in healthy children: systematic review |
| Q44448418 | Association Between Medicaid Reimbursement and Child Influenza Vaccination Rates |
| Q44792288 | Association of HLA class II genes with clinical hyporesponsiveness to trivalent inactivated influenza vaccine in children |
| Q57745653 | Attitudes and knowledge regarding influenza vaccination among hospital health workers caring for women and children |
| Q33723524 | Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4. |
| Q48370310 | Barriers and facilitators to influenza vaccination among high-risk groups aged less than 65 years - views from general practitioners and practice nurses |
| Q50969996 | Barriers to and facilitators of child influenza vaccine - perspectives from parents, teens, marketing and healthcare professionals. |
| Q36458508 | Burden of Influenza and Influenza-associated Pneumonia in the First Year of Life in a Prospective Cohort Study in Managua, Nicaragua |
| Q36377400 | Burden of Influenza-Related Hospitalizations and Attributable Mortality in Pediatric Acute Lymphoblastic Leukemia |
| Q36985282 | Burden of influenza in Germany: a retrospective claims database analysis for the influenza season 2012/2013. |
| Q34501076 | Burden of influenza in Latin America and the Caribbean: a systematic review and meta-analysis. |
| Q35277693 | Burden of influenza in healthy children and their households. |
| Q35768280 | Burden of influenza-related hospitalizations among children with sickle cell disease |
| Q34475023 | Burden of paediatric influenza in Western Europe: a systematic review |
| Q30430784 | Burden of seasonal and pandemic influenza-associated hospitalization during and after 2009 A(H1N1)pdm09 pandemic in a rural community in India |
| Q64245361 | Burden, effectiveness and safety of influenza vaccines in elderly, paediatric and pregnant populations |
| Q48129415 | Campaign Preparation for Complex Initiatives: A Person-Centered Approach to Audience Segmentation of Parents' Antibiotic Stewardship. |
| Q33603662 | Central European Vaccination Advisory Group (CEVAG) guidance statement on recommendations for influenza vaccination in children |
| Q48011448 | Challenges Remain for Influenza Vaccination of Children |
| Q33630054 | Child, household, and caregiver characteristics associated with hospitalization for influenza among children 6-59 months of age: an emerging infections program study |
| Q34044178 | Childhood Hib vaccination and pneumonia and influenza burden in US seniors |
| Q36155443 | Childhood immunisation: what is the future? |
| Q24630350 | Children with respiratory disease associated with metapneumovirus in Hong Kong |
| Q36506397 | Clinical accuracy of a PLEX-ID flu device for simultaneous detection and identification of influenza viruses A and B. |
| Q59397173 | Clinical and economic impact of influenza vaccination on healthy children aged 2–5 years |
| Q30366806 | Clinical and immune responses to inactivated influenza A(H1N1)pdm09 vaccine in children. |
| Q34047266 | Clinical and socioeconomic impact of different types and subtypes of seasonal influenza viruses in children during influenza seasons 2007/2008 and 2008/2009. |
| Q31166045 | Clinical data on Fluarix: an inactivated split seasonal influenza vaccine |
| Q30394602 | Clinical outcomes of seasonal influenza and pandemic influenza A (H1N1) in pediatric inpatients |
| Q40616686 | Clinical specifics of influenza in the child |
| Q37780548 | Clinical studies assessing immunogenicity and safety of intradermally administered influenza vaccines |
| Q92098826 | Cochrane Review: Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department |
| Q39946796 | Cocooning: Influenza Vaccine for Parents and Caregivers in an Urban, Pediatric Medical Home |
| Q51729193 | Cold-adapted live influenza vaccine versus inactivated vaccine: systemic vaccine reactions, local and systemic antibody response, and vaccine efficacy. A meta-analysis. |
| Q38123443 | Commentaries on 'procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections' with a response from the review authors. |
| Q57806795 | Comparing the Cobas Liat Influenza A/B and RSV assay with multiplex nucleic acid testing |
| Q30426234 | Comparison of a multiplex real-time PCR assay with a multiplex Luminex assay for influenza virus detection |
| Q40535330 | Comparison of clinical characteristics of influenza and respiratory syncytial virus infection in hospitalised children and adolescents |
| Q54088460 | Comparison of incidence and cost of influenza between healthy and high-risk children <60 months old in Thailand, 2011-2015. |
| Q44050535 | Consultation with health care professionals and influenza immunization among women in contact with young children. |
| Q37331059 | Contribution of influenza viruses to medically attended acute respiratory illnesses in children in high-income countries: a meta-analysis |
| Q35733952 | Control of influenza |
| Q36827449 | Cost Effectiveness of Influenza Vaccine Choices in Children Aged 2-8 Years in the U.S. |
| Q30381426 | Cost effectiveness analysis of Year 2 of an elementary school-located influenza vaccination program-Results from a randomized controlled trial |
| Q34114822 | Cost of universal influenza vaccination of children in pediatric practices |
| Q37912501 | Cost-effectiveness and socio-economic aspects of childhood influenza vaccination |
| Q40111439 | Cost-effectiveness of a new internet-based monitoring tool for neonatal post-discharge home care |
| Q74214957 | Cost-effectiveness of influenza vaccination in high-risk children in Argentina |
| Q59505997 | Cost-effectiveness of influenza vaccination of healthy children |
| Q53559924 | Cost-effectiveness of live-attenuated influenza vaccine, trivalent in preventing influenza in young children attending day-care centres. |
| Q29247948 | Cost-effectiveness of maternal influenza immunization in Bamako, Mali: A decision analysis |
| Q39780679 | Cost-effectiveness of seasonal inactivated influenza vaccination among pregnant women |
| Q34493910 | Coverage and parental perceptions of influenza vaccination among parents of children aged 6 to 23 months in Hong Kong |
| Q40005237 | Determinants of influenza vaccination among young children in an inner-city community |
| Q36630178 | Determination of Appropriate Dosing of Influenza Drugs in Pediatric Patients |
| Q36201298 | Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs |
| Q37912503 | Different influenza vaccine formulations and adjuvants for childhood influenza vaccination |
| Q44302778 | Durable immune response to inactivated H1N1 vaccine is less likely in children with sickle cell anemia receiving chronic transfusions |
| Q47777594 | Economic impact of community-acquired and nosocomial lower respiratory tract infections in young children in Germany |
| Q60286996 | Effect of Influenza Treatment with Oseltamivir on Health Outcome and Costs in Otherwise Healthy Children |
| Q44204881 | Effect of an immunization program on seasonal influenza hospitalizations in Mexican children. |
| Q36252888 | Effect of rapid influenza testing on the clinical management of paediatric influenza |
| Q30416885 | Effect of the 2009 influenza A/H1N1 pandemic on viral respiratory infections in the first year of life |
| Q37912505 | Effectiveness and safety of influenza vaccination in children: European perspective |
| Q33646793 | Effectiveness and safety of seasonal influenza vaccination in children with underlying respiratory diseases and allergy |
| Q40342526 | Effectiveness of inactivated influenza vaccine in children aged 9 months to 3 years: an observational cohort study |
| Q98189276 | Effectiveness of influenza vaccination during pregnancy to prevent severe infection in children under 6 months of age, Spain, 2017-2019 |
| Q43823774 | Effectiveness of influenza vaccination of children with recurrent respiratory tract infections in reducing respiratory-related morbidity within the households |
| Q42228543 | Effectiveness of influenza vaccine against life-threatening RT-PCR-confirmed influenza illness in US children, 2010-2012. |
| Q47580274 | Effectiveness of live attenuated influenza vaccine in preventing amoxicillin prescribing in preschool children: a self-controlled case series study. |
| Q50640927 | Effectiveness of primary care-public health collaborations in the delivery of influenza vaccine: a cluster-randomized pragmatic trial. |
| Q94662614 | Effectiveness of quadrivalent influenza vaccine in pregnant women and infants, 2018-2019 |
| Q43209676 | Efficacy and cost-effectiveness of influenza vaccination of the elderly in a densely populated and unvaccinated community |
| Q34660518 | Efficacy and safety of clearing heat and detoxifying injection in the treatment of influenza: a randomized, double-blinded, placebo-controlled trial |
| Q53892487 | Efficacy of live attenuated influenza vaccine in children: A meta-analysis of nine randomized clinical trials. |
| Q40175446 | Efficacy of maternal influenza vaccination against all-cause lower respiratory tract infection hospitalizations in young infants: Results from a randomized controlled trial |
| Q37486917 | Eleven years of Inflexal V-a virosomal adjuvanted influenza vaccine |
| Q39308116 | Enhanced and persistent antibody response against homologous and heterologous strains elicited by a MF59-adjuvanted influenza vaccine in infants and young children |
| Q38602674 | Epidemiological factors related to hospitalization due to influenza in children below 6 months of age. |
| Q64075268 | Epidemiology and burden of influenza in healthy children aged 6 to 35 months: analysis of data from the placebo arm of a phase III efficacy trial |
| Q43490574 | Epidemiology and outcomes of serious influenza-related infections in the cancer population |
| Q83381407 | Epidemiology of influenza |
| Q36759964 | Establishing the baseline burden of influenza in preparation for the evaluation of a countywide school-based influenza vaccination campaign |
| Q101571353 | Estimated influenza illnesses and hospitalizations averted by influenza vaccination among children aged 6-59 months in Suzhou, China, 2011/12 to 2015/16 influenza seasons |
| Q41928095 | Estimated rates of influenza-associated outpatient visits during 2001-2010 in six US integrated health care delivery organizations |
| Q36403778 | Estimating influenza hospitalizations among children |
| Q35476858 | Estimating influenza vaccine effectiveness using routine surveillance data among children aged 6-59 months for five consecutive influenza seasons |
| Q30942595 | Estimating influenza-related hospital admissions in older people from GP consultation data |
| Q50984534 | Estimating the clinical impact of introducing paediatric influenza vaccination in England and Wales. |
| Q30387564 | Estimating the disease burden of pandemic (H1N1) 2009 virus infection in Hunter New England, Northern New South Wales, Australia, 2009 |
| Q81685350 | Estimating the impact of childhood influenza vaccination programmes in England and Wales |
| Q40462801 | Estimating the undetected burden of influenza hospitalizations in children. |
| Q42917855 | Evaluation of a direct test for seasonal influenza in outpatients |
| Q41881421 | Evaluation of immunogenicity of the 2008-2009 seasonal influenza vaccines by microneutralization test. |
| Q30426926 | Evaluation of the Cepheid Xpert Flu Assay for rapid identification and differentiation of influenza A, influenza A 2009 H1N1, and influenza B viruses |
| Q44767209 | Evaluation of the safety, reactogenicity and immunogenicity of FluBlok trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy children aged 6-59 months |
| Q35669496 | Every nose counts: a new influenza vaccine for all healthy schoolchildren? |
| Q82910140 | Excess drug prescriptions during influenza and RSV seasons in the Netherlands: potential implications for extended influenza vaccination |
| Q91592184 | Factors affecting parental intention to vaccinate kindergarten children against influenza: A cross-sectional survey in China |
| Q38677069 | Factors associated with parental acceptance of seasonal influenza vaccination for their children - A telephone survey in the adult population in Germany |
| Q34432027 | Factors influencing childhood influenza immunization. |
| Q79850461 | Failure of inactivated influenza A vaccine to protect healthy children aged 6-24 months |
| Q40345154 | Feasibility of diagnosing influenza within 24 hours of symptom onset in children 1-3 years of age. |
| Q95811931 | Febrile respiratory tract illness in a 3-month old infant |
| Q34706374 | Frequency of drug-resistant viruses and virus shedding in pediatric influenza patients treated with neuraminidase inhibitors |
| Q35055154 | Full inactivation of human influenza virus by high hydrostatic pressure preserves virus structure and membrane fusion while conferring protection to mice against infection |
| Q40358535 | Genetic sequence analysis of influenza viruses and illness severity in ill children previously vaccinated with live attenuated or inactivated influenza vaccine |
| Q33644969 | Get the vaccine not the 'flu: Gearing up for influenza vaccine campaign 2000. |
| Q40443830 | Hand Hygiene Program Decreases School Absenteeism Due to Upper Respiratory Infections |
| Q40427971 | Hemagglutination inhibiting antibody persistence 1 year after influenza vaccination in Korean children and adolescents. |
| Q43177458 | Herd immunity in adults against influenza-related illnesses with use of the trivalent-live attenuated influenza vaccine (CAIV-T) in children |
| Q44816877 | High costs of influenza: Direct medical costs of influenza disease in young children |
| Q58580913 | Hospitalization following Outpatient Medical Care for Influenza: US Influenza Vaccine Effectiveness Network, 2011-12-2015-16 |
| Q30397814 | Hospitalized children with 2009 pandemic influenza A (H1N1): comparison to seasonal influenza and risk factors for admission to the ICU |
| Q34396426 | Human metapneumovirus infections in hospitalized children |
| Q42619323 | ICD-9 codes for identifying influenza hospitalizations in children |
| Q34099150 | Identifying pediatric age groups for influenza vaccination using a real-time regional surveillance system |
| Q34963100 | IgA and neutralizing antibodies to influenza a virus in human milk: a randomized trial of antenatal influenza immunization |
| Q43762363 | Immune response to influenza vaccination in children treated with methotrexate or/and tumor necrosis factor-alpha inhibitors |
| Q58815016 | Immunisation pendant la grossesse |
| Q37696436 | Immunization in pregnancy |
| Q81401502 | Immunization update |
| Q35682690 | Immunogenicity and Clinical Efficacy of Influenza Vaccination in Pregnancy. |
| Q36851155 | Immunogenicity and Safety of 2 Dose Levels of a Thimerosal-Free Trivalent Seasonal Influenza Vaccine in Children Aged 6-35 Months: A Randomized, Controlled Trial |
| Q35887773 | Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial |
| Q36911322 | Immunogenicity and safety of an inactivated trivalent split influenza virus vaccine in young children with recurrent wheezing |
| Q84066589 | Immunogenicity and safety of intradermal versus intramuscular route of influenza immunization in infants less than 6 months of age: a randomized controlled trial |
| Q35641291 | Impact of influenza exposure on rates of hospital admissions and physician visits because of respiratory illness among pregnant women |
| Q39963590 | Impact of influenza infection on children's hospital admissions during two seasons in Athens, Greece |
| Q35556590 | Impact of influenza on young children and the shaping of United States influenza vaccine policy |
| Q46075304 | Impact of influenza vaccination of schoolchildren on medical outcomes among all residents of Maryland |
| Q35036946 | Impact of maternal immunization on influenza hospitalizations in infants |
| Q38978360 | Impact of vaccination on influenza mortality in children <5years old in Mexico |
| Q57103282 | Impact of weather factors on influenza hospitalization across different age groups in subtropical Hong Kong |
| Q81151870 | Improved antibody responses in infants less than 1 year old using intradermal influenza vaccination |
| Q36767404 | Improving influenza immunisation for high-risk children and adolescents |
| Q40122978 | Improving influenza vaccination in chronically ill children using a tertiary-care based vaccination clinic: Is there a role for the live-attenuated influenza vaccine (LAIV)? |
| Q35205536 | Improving influenza vaccination rates of high-risk inner-city children over 2 intervention years |
| Q51246126 | In Vitro Evaluation of Absorption Characteristics of Peramivir for Oral Delivery. |
| Q81235322 | Inactivated influenza vaccine effectiveness in children under 6 years of age during the 2002-2003 season |
| Q34301431 | Inactivated influenza virus vaccines in children |
| Q40052471 | Incidence of laboratory-confirmed influenza disease among infants under 6 months of age: a systematic review |
| Q40500669 | Incidence, Morbidity, and Costs of Human Metapneumovirus Infection in Hospitalized Children |
| Q40290470 | Increased reactions to pediatric influenza vaccination following concomitant pneumococcal vaccination |
| Q47829575 | Indirect, out-of-pocket and medical costs from influenza-related illness in young children. |
| Q37284961 | Infectious diseases and vaccine sciences: strategic directions |
| Q57028463 | Influenza |
| Q57116936 | Influenza |
| Q82141762 | Influenza |
| Q30421504 | Influenza A H1N1/2009 infection in pediatric solid organ transplant recipients |
| Q40567104 | Influenza A and B virus infections in children |
| Q40169142 | Influenza A and respiratory syncytial virus hospital burden in young children in East London |
| Q37128548 | Influenza A virus among the hospitalized young children with acute respiratory infection. Is influenza A co infected with respiratory syncytial virus? |
| Q64916854 | Influenza Antiviral Prescribing Practices and the Influence of Rapid Testing Among Primary Care Providers in the US, 2009-2016. |
| Q40611833 | Influenza a in young children with suspected respiratory syncytial virus infection |
| Q34578278 | Influenza and current guidelines for its control |
| Q38068065 | Influenza and respiratory syncytial virus (RSV) vaccines for infants: safety, immunogenicity, and efficacy |
| Q45402280 | Influenza and respiratory syncytial virus in infants and children: relationship with attendance at a paediatric emergency unit and characteristics of the circulating strains |
| Q35283578 | Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps? |
| Q30329366 | Influenza diagnosis and treatment: a view from clinical practice. |
| Q40059792 | Influenza epidemiology and immunization during pregnancy: Final report of a World Health Organization working group |
| Q96292651 | Influenza immunisation in pregnancy is efficacious and safe, but questions remain |
| Q40587195 | Influenza immunization during pregnancy: Benefits for mother and infant |
| Q47331095 | Influenza immunization policies: Which could be the main reasons for differences among countries? |
| Q47449576 | Influenza in children: the German perspective |
| Q58066884 | Influenza in pediatric solid-organ transplant recipients |
| Q25256568 | Influenza in tropical regions |
| Q36153722 | Influenza related hospital admissions in children: evidence about the burden keeps growing but the route to policy change remains uncertain |
| Q36153678 | Influenza related hospitalisations in Sydney, New South Wales, Australia. |
| Q33395525 | Influenza vaccination among healthcare workers in a multidisciplinary University hospital in Italy |
| Q81559635 | Influenza vaccination among healthcare workers in a university children's hospital |
| Q35158303 | Influenza vaccination coverage and effectiveness in young children in Thailand, 2011-2013 |
| Q30411868 | Influenza vaccination coverage rate in children: reasons for a failure and how to go forward |
| Q39435460 | Influenza vaccination during pregnancy for prevention of influenza confirmed illness in the infants: a systematic review and meta-analysis |
| Q40096935 | Influenza vaccination in paediatric nurses: cross-sectional study of coverage, refusal, and factors in acceptance |
| Q30366784 | Influenza vaccination in pregnancy: current evidence and selected national policies. |
| Q30350930 | Influenza vaccination in the elderly: impact on hospitalisation and mortality. |
| Q64090707 | Influenza vaccination of pregnant women in Paris, France: Knowledge, attitudes and practices among midwives |
| Q37481353 | Influenza vaccination options to prevent hospitalization. |
| Q33652685 | Influenza vaccination rates of children in households with high-risk adults |
| Q36136123 | Influenza vaccination type, live, attenuated influenza vaccine (LAIV) versus inactivated influenza vaccine (IIV), received by children, United States, 2011-12 through 2013-14 influenza seasons |
| Q36652357 | Influenza vaccination: the paediatric perspective |
| Q83011818 | Influenza vaccine after pediatric kidney transplant: a Midwest Pediatric Nephrology Consortium study |
| Q43175567 | Influenza vaccine effectiveness and confounding factors among young children |
| Q36783905 | Influenza vaccine effectiveness by test-negative design - Comparison of inpatient and outpatient settings |
| Q24628863 | Influenza vaccine given to pregnant women reduces hospitalization due to influenza in their infants |
| Q57560041 | Influenza vaccine in healthy children: a meta-analysis |
| Q36383823 | Influenza vaccine in patients with asthma |
| Q30363575 | Influenza vaccine programs and pregnancy: new Canadian evidence for immunization. |
| Q41934389 | Influenza vaccine use to protect healthy children: A debated topic |
| Q34218554 | Influenza vaccine: issues and opportunities |
| Q34189122 | Influenza vaccines: a review and rationale for use in developed and underdeveloped countries. |
| Q35076812 | Influenza viral load and peramivir kinetics after single administration and proposal of regimens for peramivir administration against resistant variants |
| Q42177564 | Influenza virus surveillance among young children in São Paulo, Brazil: the impact of vaccination |
| Q55367968 | Influenza virus: 16 years' experience of clinical epidemiologic patterns and associated infection factors in hospitalized children in Argentina. |
| Q57384999 | Influenza- and RSV-associated hospitalizations among adults |
| Q25256617 | Influenza-associated hospitalization in a subtropical city |
| Q34320911 | Influenza-associated hospitalizations, Singapore, 2004-2008 and 2010-2012. |
| Q39601092 | Influenza-associated mortality in Hong Kong |
| Q42259236 | Influenza-associated pediatric deaths in the United States, 2004-2012. |
| Q55077094 | Influenza-associated pneumonia in children hospitalized with laboratory-confirmed influenza, 2003-2008. |
| Q37726768 | Influenza-related healthcare visits, hospital admissions, and direct medical costs for all children aged 2 to 17 years in a defined Swedish region, monitored for 7 years |
| Q43614574 | Influenza-related hospitalisations among children aged less than 5 years old in the Basque Country, Spain: a 3-year study (July 2001-June 2004). |
| Q34785408 | Influenza-related hospitalization and ED visits in children less than 5 years: 2000-2011. |
| Q56762471 | Influenza-related morbidity and mortality among children in developed and developing countries |
| Q73235290 | Influenza: New Insights Into an Old Disease |
| Q30405546 | Influenza: clinical symptoms, diagnostics and therapy |
| Q37812615 | Influvac, a trivalent inactivated subunit influenza vaccine. |
| Q37812124 | Intanza®: a new intradermal vaccine for seasonal influenza |
| Q30228581 | Interaction between influenza virus and Streptococcus pneumoniae in severe pneumonia |
| Q38646313 | Interventions to increase the uptake of seasonal influenza vaccination among pregnant women: A systematic review. |
| Q41646010 | Is Infant Immunity Actively Suppressed or Immature? |
| Q36360529 | Is influenza vaccination in asthmatic children helpful? |
| Q30239895 | Japanese Surveillance Systems and Treatment for Influenza |
| Q38386015 | Kaiser Permanente Northern California pregnancy database: Description and proof of concept study |
| Q40607371 | Knowledge and attitiudes of pregnant women and their providers towards recommendations for immunization during pregnancy |
| Q37530356 | Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period |
| Q42256030 | Knowledge, attitudes, and practices of school personnel regarding influenza, vaccinations, and school outbreaks. |
| Q94361023 | Les avantages d’administrer le vaccin antigrippal pendant la grossesse pour le fœtus et le nourrisson de moins de six mois |
| Q55618024 | Les avantages d’administrer le vaccin antigrippal pendant la grossesse pourle fœtus et le nourrisson de moins de six mois. |
| Q38416489 | Live attenuated influenza vaccine tetravalent: a clinical review |
| Q34337076 | Live attenuated influenza vaccine, trivalent, is safe in healthy children 18 months to 4 years, 5 to 9 years, and 10 to 18 years of age in a community-based, nonrandomized, open-label trial |
| Q34324982 | Live attenuated influenza virus vaccines: new options for the prevention of influenza |
| Q57451108 | Long-term immunogenicity of a virosomal subunit inactivated influenza vaccine in children with asthma |
| Q35034566 | Low immunogenicity of seasonal trivalent influenza vaccine among patients receiving docetaxel for a solid tumour: results of a prospective pilot study |
| Q56791521 | Low reactogenicity of the virosomal subunit influenza vaccine in healthy children without risk factors |
| Q37706610 | MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk |
| Q37087071 | Marketing paediatric influenza vaccination: results of a major metropolitan trial. |
| Q33836970 | Maternal antibodies protect offspring from severe influenza infection and do not lead to detectable interference with subsequent offspring immunization |
| Q75251357 | Maternal immunization |
| Q40195938 | Maternal influenza immunisation to reduce influenza infections and low birthweight in infants in resource-limited countries |
| Q42246870 | Maternal influenza vaccination: evaluation of a patient-centered pamphlet designed to increase uptake in pregnancy |
| Q30386781 | Maternal vaccination for the prevention of influenza: current status and hopes for the future. |
| Q37403809 | Meta-analysis of medical regimen adherence outcomes in pediatric solid organ transplantation |
| Q45368981 | Monitoring epidemic viral respiratory infections using one-step real-time triplex RT-PCR targeting influenza A and B viruses and respiratory syncytial virus |
| Q40470206 | Multiplex real-time PCR assay for detection of influenza and human respiratory syncytial viruses. |
| Q34769475 | Near patient testing for influenza in children in primary care: comparison with laboratory test |
| Q24243136 | Neuraminidase inhibitors for preventing and treating influenza in children |
| Q24247957 | Neuraminidase inhibitors for preventing and treating influenza in children |
| Q35045959 | Neuraminidase inhibitors in pediatric patients: potential place in influenza therapy |
| Q46659780 | No association between influenza vaccination during pregnancy and adverse birth outcomes |
| Q30350342 | Novel strategies for prevention and treatment of influenza. |
| Q92711478 | Oil-in-water emulsion adjuvants for pediatric influenza vaccines: a systematic review and meta-analysis |
| Q30373196 | Organization of intensive care in situation of avian flu pandemic |
| Q38652336 | Oseltamivir for influenza infection in children: risks and benefits |
| Q36584645 | Oseltamivir pharmacokinetics, dosing, and resistance among children aged <2 years with influenza |
| Q37828363 | Oseltamivir treatment and prophylaxis in a neonatal intensive care unit during a 2009 H1N1 influenza outbreak |
| Q51150895 | Outpatient Antibiotic Prescription Trends in the United States: A National Cohort Study. |
| Q55666271 | Outpatient antibiotic use in Dutch infants after 10-valent pneumococcal vaccine introduction: a time-series analysis. |
| Q33720358 | Outpatient physician billing data for age and setting specific syndromic surveillance of influenza-like illnesses |
| Q45734831 | Overlap between respiratory syncytial virus infection and influenza |
| Q35124715 | Paediatric community-acquired pneumonia: current concept in pharmacological control |
| Q30360119 | Pandemic influenza A vs seasonal influenza A in hospitalized children in Athens. |
| Q30375649 | Parental perceptions and predictors of consent for school-located influenza vaccination in urban elementary school children in the United States |
| Q34886641 | Parental perspectives on influenza vaccination among children with asthma |
| Q35880283 | Pediatric influenza prevention and control |
| Q37086279 | Pediatric influenza-associated myositis - Nebraska, 2001-2007. |
| Q40362838 | Performance of rapid influenza testing in hospitalized children |
| Q44544248 | Pharmacokinetics of anti-influenza prodrug oseltamivir in children aged 1-5 years |
| Q30227641 | Pneumococcal pneumonia and influenza: a deadly combination |
| Q36513346 | Pneumonia research to reduce childhood mortality in the developing world |
| Q43177595 | Poor immune responses to influenza vaccination in infants |
| Q51980197 | Population-wide benefits of routine vaccination of children against influenza. |
| Q30353815 | Post-exposure influenza prophylaxis with oseltamivir: cost effectiveness and cost utility in families in the UK. |
| Q36903940 | Practice and Child Characteristics Associated With Influenza Vaccine Uptake in Young Children |
| Q64447687 | Pre-conception maternal helminth infection transfers via nursing long-lasting cellular immunity against helminths to offspring |
| Q83571165 | Pregnant women's knowledge of influenza and the use and safety of the influenza vaccine during pregnancy |
| Q38637989 | Prematurity and the burden of influenza and respiratory syncytial virus disease |
| Q30375316 | Prevalence and associated factors of seasonal influenza vaccination among 24- to 59-month-old children in Hong Kong. |
| Q42248401 | Prevalence and predictors of maternal seasonal influenza vaccination in Hong Kong |
| Q30398281 | Prevalence of antibodies against seasonal influenza A and B viruses in children in Netherlands |
| Q37017252 | Prevention and control of influenza in persons with chronic obstructive pulmonary disease |
| Q35943670 | Prevention of influenza in the general population |
| Q37596393 | Prevention of influenza in the general population: recommendation statement from the Canadian Task Force on Preventive Health Care |
| Q49587453 | Prevention of influenza-related illness in young infants by maternal vaccination during pregnancy |
| Q30418041 | Prevention of novel influenza infection in newborns in hospital settings: considerations and strategies during the 2009 H1N1 pandemic |
| Q57927674 | Prevention of vaccine-matched and mismatched influenza in children aged 6-35 months: a multinational randomised trial across five influenza seasons |
| Q37394608 | Private Pediatric Clinic Characteristics Associated with Influenza Immunization Efforts in the State of Georgia: A Pilot Evaluation |
| Q33953754 | Promises and challenges of live-attenuated intranasal influenza vaccines across the age spectrum: a review |
| Q53995348 | Promoting appropriate antimicrobial drug use: perspective from the Centers for Disease Control and Prevention. |
| Q31992333 | Prophylactic and symptomatic treatment of influenza. Current and developing options |
| Q47925908 | Prospective population-based study of viral lower respiratory tract infections in children under 3 years of age (the PRI.DE study). |
| Q33588918 | Protecting young babies from influenza |
| Q27693242 | Protection of young children from influenza through universal vaccination. |
| Q45324173 | Protective Effect of Panax notoginseng Root Water Extract against Influenza A Virus Infection by Enhancing Antiviral Interferon-Mediated Immune Responses and Natural Killer Cell Activity |
| Q50234343 | Protéger les jeunes bébés contre la grippe |
| Q39625974 | QuickVue influenza test for rapid detection of influenza A and B viruses in a pediatric population |
| Q47809619 | Rapid Tests for Influenza |
| Q24193608 | Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department |
| Q24198023 | Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department |
| Q24240121 | Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department |
| Q24245866 | Rapid viral diagnosis for acute febrile respiratory illness in children in the Emergency Department |
| Q43626562 | Rates of hospitalisation for influenza, respiratory syncytial virus and human metapneumovirus among infants and young children |
| Q36187779 | Rationale and design of the prevention of respiratory infections and management in children (PRIMAKid) study: a randomized controlled trial on the effectiveness and costs of combined influenza and pneumococcal vaccination in pre-school children with |
| Q39647922 | Reasons why women accept or reject the trivalent inactivated influenza vaccine (TIV) during pregnancy |
| Q94352812 | Recommandations quant à l’usage du vaccin contre l’influenza chez les enfants |
| Q84354864 | Recommendations for the use of influenza vaccine for children |
| Q36195711 | Recurrent plastic bronchitis in a child with 2009 influenza A (H1N1) and influenza B virus infection |
| Q47991306 | Recurrent respiratory tract infections in pediatric age: a population-based survey of the therapeutic role of macrolides. |
| Q37496797 | Reducing the burden of influenza-associated complications with antiviral therapy |
| Q36145000 | Reducing the impact of viral respiratory infections in children |
| Q36030806 | Relative impact of influenza and respiratory syncytial virus in young children |
| Q45725286 | Renal involvement in children with influenza A virus infection. |
| Q35913412 | Respiratory Viruses Associated Hospitalization among Children Aged <5 Years in Bangladesh: 2010-2014. |
| Q35673288 | Respiratory fluoroquinolone use and influenza |
| Q42726029 | Respiratory viral testing: new frontiers in diagnostics and implications for antimicrobial stewardship. |
| Q33605739 | Respiratory viruses in bronchiolitis and their link to recurrent wheezing and asthma |
| Q82690620 | Respiratory viruses transmission from children to adults within a household |
| Q30420381 | Risk factors for mechanical ventilation in U.S. children hospitalized with seasonal influenza and 2009 pandemic influenza A*. |
| Q36589247 | Rituximab-treated patients have a poor response to influenza vaccination |
| Q35875663 | Role of influenza vaccine for healthy children in the US. |
| Q35268325 | Routine influenza vaccination for healthy children--old concept, new technologies |
| Q59397023 | Safe administration of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg allergy |
| Q36009663 | Safety and Immunogenicity of Full-Dose Trivalent Inactivated Influenza Vaccine (TIV) Compared With Half-Dose TIV Administered to Children 6 Through 35 Months of Age. |
| Q35268453 | Safety and immunogenicity of a paediatric presentation of an influenza vaccine |
| Q37086288 | Safety and immunogenicity of an inactivated thimerosal-free influenza vaccine in infants and children |
| Q37172964 | Safety and immunogenicity of trivalent inactivated influenza vaccine in infants |
| Q43175540 | Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China |
| Q83876420 | Safety of live attenuated influenza vaccine in mild to moderately immunocompromised children with cancer |
| Q36990293 | Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. |
| Q30376021 | School closure may be effective in reducing transmission of respiratory viruses in the community. |
| Q30210618 | School-based influenza vaccination: parents' perspectives |
| Q51176333 | School-based influenza vaccine delivery, vaccination rates, and healthcare use in the context of a universal influenza immunization program: an ecological study. |
| Q30419114 | Seasonal and pandemic influenza: an overview with pediatric focus |
| Q48585293 | Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America |
| Q30387979 | Seasonal influenza vaccination of high-risk adults |
| Q34146066 | Seasonal influenza vaccine effectiveness among children aged 6 to 59 months in southern China |
| Q36251600 | Seasonal influenza vaccine effectiveness among children, 2010-2012. |
| Q42736638 | Seasonal influenza vaccine effectiveness in children during 2010-2011 season: a case-cohort study |
| Q37912499 | Seasonal influenza: the burden of disease in children |
| Q35084010 | Seasonal patterns of hospital use in Winnipeg: implications for managing winter bed crises |
| Q40389395 | Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age. |
| Q51128149 | Seroprevalence of influenza A and B in German infants and adolescents. |
| Q39454744 | Severe influenza in children: incidence and risk factors |
| Q36348822 | Should healthy children be vaccinated against influenza? A consensus report of the Summits of Independent European Vaccination Experts. |
| Q45218285 | Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011. |
| Q34073615 | Signs and symptoms predicting influenza in children: a matched case-control analysis of prospectively collected clinical data |
| Q30834597 | Single- and multiple viral respiratory infections in children: disease and management cannot be related to a specific pathogen |
| Q34946122 | Socio-economic burden of influenza among children younger than 5 years in the outpatient setting in Suzhou, China |
| Q40548573 | Socioeconomic impact of influenza on healthy children and their families |
| Q46446436 | Study of the impact of oseltamivir on the risk for pneumonia and other outcomes of influenza, 2000-2005. |
| Q38448647 | Surveillance of childhood influenza virus infection: what is the best diagnostic method to use for archival samples? |
| Q35154424 | The Hi Five study: design of a school-based randomized trial to reduce infections and improve hygiene and well-being among 6-15 year olds in Denmark. |
| Q22242904 | The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America |
| Q37710338 | The association between influenza treatment and hospitalization-associated outcomes among Korean children with laboratory-confirmed influenza |
| Q40662861 | The battle against influenza: The role of neuraminidase inhibitors in children |
| Q41835008 | The battle against influenza: The role of neuraminidase inhibitors in children. |
| Q94361019 | The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age |
| Q34531879 | The benefits of influenza vaccine in pregnancy for the fetus and the infant younger than six months of age. |
| Q40658168 | The burden of community-managed acute respiratory infections in the first 2-years of life. |
| Q50132581 | The burden of influenza-like illness in the US workforce |
| Q57792698 | The burden of respiratory viral disease in hospitalized children in Paris |
| Q30430303 | The burden of seasonal and pandemic influenza in infants and children |
| Q30351241 | The clinical presentation and outcomes of children infected with newly identified respiratory tract viruses |
| Q36493927 | The cost of community-managed viral respiratory illnesses in a cohort of healthy preschool-aged children |
| Q92606969 | The effectiveness of influenza vaccination in pregnancy in relation to child health outcomes: Systematic review and meta-analysis |
| Q43173350 | The effectiveness of trivalent inactivated influenza vaccine in children over six consecutive influenza seasons |
| Q90554409 | The efficacy, effectiveness, and immunogenicity of influenza vaccines in Africa: a systematic review |
| Q31148484 | The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study |
| Q33547664 | The epidemiology of hospitalized influenza in children, a two year population-based study in the People's Republic of China |
| Q36055988 | The human side of influenza |
| Q30432137 | The impact of influenza and respiratory syncytial virus on hospitalizations for lower respiratory tract infections in young children: Slovenia, 2006-2011. |
| Q45709846 | The impact of influenza viruses on hospitalizations in infants younger than two years old during epidemics of respiratory syncytial virus infection |
| Q35065146 | The impact of influenza-associated respiratory illnesses on hospitalizations, physician visits, emergency room visits, and mortality. |
| Q37946432 | The ins and outs of universal childhood influenza vaccination |
| Q44704491 | The need for validation of statistical methods for estimating respiratory virus-attributable hospitalization |
| Q30369192 | The organisation of intensive care in a situation of pandemic avian influenza |
| Q28743825 | The population impact of a large school-based influenza vaccination campaign |
| Q45324551 | The risk of lower respiratory tract infection following influenza virus infection: A systematic and narrative review |
| Q35927044 | The role of heterogeneity in contact timing and duration in network models of influenza spread in schools |
| Q74443852 | The role of live influenza vaccines in children |
| Q30364977 | The role of oseltamivir in the treatment and prevention of influenza in children. |
| Q34769368 | The safety and immunogenicity of trivalent inactivated influenza vaccination: a study of maternal-cord blood pairs in Taiwan. |
| Q37678409 | The virosomal adjuvanted influenza vaccine |
| Q84170208 | Trivalent inactivated influenza vaccine (TIV) immunogenicity in children 6 through 23 months of age: do children of all ages respond equally? |
| Q37135432 | Understanding motivators and barriers of hospital-based obstetric and pediatric health care worker influenza vaccination programs in Australia |
| Q30395309 | Vaccination against pneumococci and influenza. How good is the evidence? |
| Q43820942 | Vaccination during pregnancy to protect infants against influenza: why and why not? |
| Q33728238 | Vaccination updates |
| Q36964157 | Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons |
| Q40311136 | Vaccine effectiveness for laboratory-confirmed influenza in children 6-59 months of age, 2005-2007. |
| Q89526678 | Vaccine hesitancy and influenza beliefs among parents of children requiring a second dose of influenza vaccine in a season: An American Academy of Pediatrics (AAP) Pediatric Research in Office Settings (PROS) study |
| Q34419670 | Vaccines for pneumonia and new antiviral therapies |
| Q24201525 | Vaccines for preventing influenza in healthy children |
| Q24243174 | Vaccines for preventing influenza in healthy children |
| Q24244954 | Vaccines for preventing influenza in healthy children |
| Q57272289 | Vaccines for preventing influenza in healthy children |
| Q47638511 | Vaccines for preventing influenza in healthy children |
| Q34218618 | Vaccines in pregnancy |
| Q37947937 | Validity of parental report of influenza vaccination in young children seeking medical care |
| Q24805596 | Values for preventing influenza-related morbidity and vaccine adverse events in children |
| Q35546257 | Viral Characteristics of Influenza |
| Q40751509 | Viral Infections in Children in the 2014/2015 Epidemic Season in Poland. |
| Q36830101 | Viral aetiology in adults with acute upper respiratory tract infection in Jinan, Northern China |
| Q30434249 | Viral infections in relation to age, atopy, and season of admission among children hospitalized for wheezing |
| Q33815604 | Viral lower respiratory tract infection in infants and young children |
| Q47947957 | Virological surveillance of influenza-like illness in the community using PCR and serology |
| Q35023496 | Virosome influenza vaccine in children. |
| Q33811438 | Viruses and asthma |
| Q41929328 | Web-Based Surveillance of Illness in Childcare Centers. |
| Q43176395 | Who gets hospitalized for influenza pneumonia in Thailand? Implications for vaccine policy |
| Q82865211 | [Human bocavirus infections] |
| Q80025027 | [Infection by influenza virus in childhood: a call for broader influenza vaccination] |
| Q74167922 | [Influenza: antibiotics and other treatments] |
| Q74042281 | [Multicenter study of children's compliance to antibiotic treatment in primary care] |
| Q73181776 | [Prevention of influenza in children] |
| Q83372412 | [Seasonal flu] |
Search more.